ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Gsk Plc GSK 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
12.50 0.76% 1,653.00 00:35:15
개장가 저가 고가 종가 전일 종가
1,638.50 1,634.00 1,655.50 1,653.00 1,640.50
시세 정보 더보기 »
산업 분야
PHARMACEUTICALS & BIOTECHNOLOGY

최근 뉴스

일자 시간 출처 제목
24/04/202417:14ALNCNewsGSK's Jemperli with chemotherapy accepted for priority..
24/04/202415:00UK RNSGSK PLC US FDA accepts new indication filing for Jemperli
19/04/202423:30UK RNSGSK PLC Director/PDMR Shareholding
17/04/202423:30UK RNSGSK PLC Director/PDMR Shareholding
17/04/202416:46ALNCNewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea..
17/04/202415:05UK RNSGSK PLC GSK announces additional EAGLE-1 results
17/04/202415:00UK RNSGSK PLC Results from long-term data relating to Shingrix
16/04/202422:11UK RNSGSK PLC Amendment - Director/PDMR Shareholding
16/04/202416:59ALNCNewsGSK's latest meningitis vaccine accepted for review by US..
16/04/202415:00UK RNSGSK PLC FDA accepts GSK meningitis vaccine candidate file
15/04/202423:30UK RNSGSK PLC Director/PDMR Shareholding
08/04/202418:27ALNCNewsIN THE KNOW: Barclays ups GSK price target but HIV drug..
04/04/202420:05UK RNSGSK PLC Replacement - Total Voting Rights
02/04/202423:00UK RNSGSK PLC Total Voting Rights
27/03/202400:30UK RNSGSK PLC Director/PDMR Shareholding
25/03/202422:00UK RNSGSK PLC Notice of AGM
23/03/202401:20UK RNSGSK PLC Transfer of Treasury Shares
23/03/202400:36UK RNSGSK PLC Director/PDMR Shareholding
18/03/202418:30UK RNSGSK PLC New Phase III Jemperli data in endometrial cancer
18/03/202417:47ALNCNewsGSK says Jemperli combination gets good results for..
14/03/202400:48UK RNSGSK PLC Director/PDMR Shareholding
09/03/202402:12UK RNSGSK PLC Board Committee Change
07/03/202418:38ALNCNewsGSK observes positive data in Blenrep trial for blood cancer..
07/03/202416:00UK RNSGSK PLC GSK announces positive Blenrep DREAMM-8 results
07/03/202401:00UK RNSGSK PLC ViiV LAI vs oral SOC data in adherence-challenged
06/03/202402:24UK RNSGSK PLC GSK Annual Report 2023 on Form 20-F
05/03/202420:03ALNCNewsGSK says ViiV's cabotegravir study supports longer HIV dose..
05/03/202416:00UK RNSGSK PLC New ViiV LA formulation potential 4-month dosing
02/03/202400:00UK RNSGSK PLC Total Voting Rights
01/03/202421:15UK RNSGSK PLC GSK publishes Annual Report 2023
29/02/202418:44ALNCNewsTOP NEWS: GSK avoids "protracted litigation" with Zantac..
29/02/202416:05UK RNSGSK PLC Directorate Change
29/02/202416:00UK RNSGSK PLC Statement: Zantac (ranitidine) litigation
27/02/202400:30UK RNSGSK PLC Director/PDMR Shareholding
26/02/202417:25ALNCNewsGSK gonorrhoea treatment achieves efficacy endpoint in..
26/02/202416:00UK RNSGSK PLC GSK announces positive EAGLE-1 headline results
23/02/202400:30UK RNSGSK PLC Director/PDMR Shareholding
21/02/202418:47ALNCNewsGSK reports encouraging results for ViiV's Cabenuva HIV..
21/02/202416:00UK RNSGSK PLC ViiV LAI superior to orals in adherence-challenged
20/02/202418:01UK RNSGSK PLC Julie Brown - External Appointment
20/02/202400:30UK RNSGSK PLC Director/PDMR Shareholding
16/02/202400:32UK RNSGSK PLC Director/PDMR Shareholding
15/02/202417:49ALNCNewsGSK completes USD1.4 billion purchase of respiratory firm..
15/02/202416:00UK RNSGSK PLC GSK completes acquisition of Aiolos Bio
14/02/202401:45UK RNSGSK PLC Director/PDMR Shareholding - Replacement
14/02/202400:40UK RNSGSK PLC Director/PDMR Shareholding
14/02/202400:35UK RNSGSK PLC Director/PDMR Shareholding
14/02/202400:30UK RNSGSK PLC Director/PDMR Shareholding
13/02/202417:25ALNCNewsIN THE KNOW: Citi turns positive on GSK after seven years on..
13/02/202400:39UK RNSGSK PLC Director/PDMR Shareholding

최근 히스토리

Delayed Upgrade Clock